Fierce Biotech Layoff Tracker 2024. Obviously a very tough year in the industry. Arbutus biopharma will lay off 40% of its staff in order to focus resources on its phase ii treatment for chronic hepatitis b infection, the company announced as part of its q2 financial results on thursday.


Fierce Biotech Layoff Tracker 2024

Affimed dissolves research and preclinical teams; Fierce biotech layoff tracker 2024 clara demetra, affimed dissolves research and preclinical teams;

Fierce Biotech Layoff Tracker 2024 Images References :